We are live on !
Find out more
Cliff Asness AQR Capital Management
AUM
$287B
Turnover
8.35%
1-Year Est. Return
42.33%
Cliff Asness is a co-founder of AQR Capital Management, a leading quantitative investment firm spanning equities, alternatives, and factor strategies. He is known for academic-informed research on value, momentum, and other systematic premia, as well as candid market commentary. Asness’s work bridges academic finance and large-scale institutional portfolio management.
This Fund
S&P 500
This Quarter Est. Return
+22.95%
1 Year Est. Return
+42.33%
3 Year Est. Return
+119.89%
5 Year Est. Return
+147.33%
10 Year Est. Return
+543.74%
AUM
$287B
AUM Growth
+$68.5B
(+31%)
Cap. Flow
+$37.5B
Cap. Flow % of AUM
Cap. Flow %
13.08%
Top 10 Holdings %
Top 10 Hldgs %
12.15%
Holding
3,986
New
247
Increased
2,455
Reduced
1,098
Closed
86
Avg Time Held
4.1
years
Top 10 Avg Time Held
3.3
years
Top 20 Avg Time Held
2.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
NVIDIA
NVDA
|
+$1.17B |
| 2 |
Apple
AAPL
|
+$849M |
| 3 |
Chevron
CVX
|
+$746M |
| 4 |
Synopsys
SNPS
|
+$643M |
| 5 |
Wells Fargo
WFC
|
+$633M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Micron Technology
MU
|
+$517M |
| 2 |
Booking.com
BKNG
|
+$488M |
| 3 |
Walmart Inc
WMT
|
+$414M |
| 4 |
Sandisk
SNDK
|
+$355M |
| 5 |
Cigna
CI
|
+$325M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 25.5% |
| 2 | Financials | 14.38% |
| 3 | Industrials | 14.2% |
| 4 | Consumer Discretionary | 10.53% |
| 5 | Healthcare | 10.4% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
2601
Yum China
YUMC
$15.4B
| $2.06M | ﹤0.01% |
50,574
-591,843
| -92% | -$27.1M |
2016 Q4
38 quarters
|
|
2602
iShares S&P Small-Cap 600 Growth ETF
IJT
$7.68B
| $2.06M | ﹤0.01% |
11,537
+1,260
| +12% | +$204K |
2024 Q4
6 quarters
|
|
2603
Neighborhood Intelligence Inc
NXH
$168M
| $2.06M | ﹤0.01% |
355,100
+67,393
| +23% | +$370K |
2026 Q1
1 quarter
|
|
2604
Jakks Pacific
JAKK
$362M
| $2.05M | ﹤0.01% |
88,083
-16,689
| -16% | -$370K |
2024 Q1
9 quarters
|
|
2605
Saul Centers
BFS
$719M
| $2.05M | ﹤0.01% |
54,729
+6,789
| +14% | +$237K |
2015 Q1
45 quarters
|
|
2606
Arbor Realty Trust
ABR
$394M
| $2.04M | ﹤0.01% |
376,371
+180,021
| +92% | +$1.17M |
2020 Q3
23 quarters
|
|
2607
Addus HomeCare
ADUS
$2.34B
| $2.04M | ﹤0.01% |
20,281
+12,315
| +155% | +$1.16M |
2013 Q2
52 quarters
|
|
2608
Spyre Therapeutics
SYRE
$9.02B
| $2.04M | ﹤0.01% |
22,937
+2,063
| +10% | +$151K |
2025 Q2
4 quarters
|
|
2609
Capital City Bank Group
CCBG
$871M
| $2.03M | ﹤0.01% |
41,127
+8,665
| +27% | +$401K |
2024 Q3
7 quarters
|
|
2610
iShares MSCI Japan Value ETF
EWJV
$757M
| $2.03M | ﹤0.01% |
+46,175
| New | +$2.05M |
2026 Q2
0 quarters
|
|
2611
Humacyte
HUMA
$114M
| $2.03M | ﹤0.01% |
2,597,134
+672,443
| +35% | +$623K |
2023 Q4
10 quarters
|
|
2612
Forward Air
FWRD
$595M
| $2.02M | ﹤0.01% |
149,756
+95,117
| +174% | +$1.42M |
2026 Q1
1 quarter
|
|
2613
Trade Desk
TTD
$5.81B
| $2.02M | ﹤0.01% |
114,420
-475,760
| -81% | -$10.1M |
2023 Q2
12 quarters
|
|
2614
Stock Yards Bancorp
SYBT
$2.44B
| $2.02M | ﹤0.01% |
26,414
+19,384
| +276% | +$1.39M |
2024 Q4
6 quarters
|
|
2615
iShares Russell Top 200 Growth ETF
IWY
$15.2B
| $2.02M | ﹤0.01% |
6,941
+641
| +10% | +$181K |
2024 Q2
8 quarters
|
|
2616
Phibro Animal Health
PAHC
$1.58B
| $2.02M | ﹤0.01% |
64,238
+6,720
| +12% | +$284K |
2024 Q1
9 quarters
|
|
2617
Merchants Bancorp
MBIN
$2.39B
| $2.01M | ﹤0.01% |
40,280
+1,968
| +5% | +$93.5K |
2021 Q1
21 quarters
|
|
2618
Vaxcyte
PCVX
$9.8B
| $2.01M | ﹤0.01% |
34,563
+9,105
| +36% | +$495K |
2025 Q4
2 quarters
|
|
2619
Titan America SA
TTAM
$2.56B
| $2.01M | ﹤0.01% |
107,591
+21,956
| +26% | +$361K |
2025 Q3
3 quarters
|
|
2620
FT Vest Laddered Moderate Buffer ETF
BUFZ
$1.1B
| $2M | ﹤0.01% |
71,750
-1,441
| -2% | -$39.6K |
2024 Q3
7 quarters
|
|
2621
Advantage Solutions
ADV
$388M
| $2M | ﹤0.01% |
46,323
+32,797
| +242% | +$1.16M |
2023 Q4
10 quarters
|
|
2622
GeneDx Holdings
WGS
$2.06B
| $2M | ﹤0.01% |
29,172
+10,782
| +59% | +$613K |
2024 Q3
7 quarters
|
|
2623
Invesco FTSE RAFI Developed Markets ex-US ETF
PXF
$2.93B
| $2M | ﹤0.01% |
26,440
+10,469
| +66% | +$787K |
2025 Q4
2 quarters
|
|
2624
Avantis All Equity Markets Value ETF
AVGV
$479M
| $1.98M | ﹤0.01% |
23,325
+288
| +1% | +$24K |
2026 Q1
1 quarter
|
|
2625
Invesco S&P 500 High Dividend Low Volatility ETF
SPHD
$3.41B
| $1.98M | ﹤0.01% |
38,963
| – | – |
2025 Q3
3 quarters
|
|
Similar funds
Cliff Asness's Q2 2026 Portfolio in Review
As of Q2 2026, Cliff Asness held 3,986 positions worth $287B, up 31% from $218B the previous quarter. Its ten largest holdings account for 12% of the portfolio.
Cliff Asness deployed $37.5B of net new capital in Q2 2026, opening 247 new positions and adding to 2,455 existing holdings. Its largest new stake was FedEx Freight: 1,024,555 shares worth $155M.
By sector, the portfolio is most concentrated in Technology at 25% of assets, up from 22% a quarter earlier, followed by Financials and Industrials.
On the sell side, the largest reduction was Micron Technology, an estimated $517M trimmed.
- Cliff Asness's largest Q2 2026 buy was FedEx Freight: 1,024,555 shares worth $155M.
- Cliff Asness added most to NVIDIA in Q2 2026, an estimated $1.17B increase.
- Cliff Asness's biggest Q2 2026 reduction was Micron Technology, cutting an estimated $517M.
- Cliff Asness fully exited Masimo in Q2 2026, selling an estimated $147M.
- Cliff Asness's ten largest holdings make up 12% of its $287B portfolio in Q2 2026.
- Cliff Asness opened 247 new positions and closed 86 in Q2 2026.
- Cliff Asness's portfolio value rose 31% quarter-over-quarter to $287B.
Based on AQR Capital Management's 13F filing for Q2 2026, filed 14 Aug 2026.